emodin has been researched along with epiglucan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyvärinen, A; Kirjavainen, P; Koistinen, A; Komulainen, H; Korkalainen, M; Naarala, J; Täubel, M; Viluksela, M | 1 |
| Chen, Q; Dai, L; Dong, L; Gao, F; Han, X; He, H; Lin, D; Lin, M; Luo, R; Nie, W; Pu, X; Qi, S; Wang, Y; Xu, H; Ye, N | 1 |
2 other study(ies) available for emodin and epiglucan
| Article | Year |
|---|---|
Synergistic proinflammatory interactions of microbial toxins and structural components characteristic to moisture-damaged buildings.
Topics: Air Pollution, Indoor; Bacteria; beta-Glucans; Depsipeptides; Emodin; Enzyme-Linked Immunosorbent Assay; Fungi; Humans; Interleukin-1beta; Lipopolysaccharides; Macrophages; Real-Time Polymerase Chain Reaction; Sterigmatocystin; THP-1 Cells; Tumor Necrosis Factor-alpha; Valinomycin | 2017 |
β-1,3-d-Glucan based yeast cell wall system loaded emodin with dual-targeting layers for ulcerative colitis treatment.
Topics: Animals; Anti-Inflammatory Agents; beta-Glucans; Caco-2 Cells; Cardiac Myosins; Cell Wall; Colitis, Ulcerative; Colon; Drug Carriers; Drug Liberation; Emodin; Humans; Intestinal Mucosa; Lactoferrin; Mice; Myosin Light Chains; Myosin-Light-Chain Kinase; Nanoparticles; NF-kappa B; Saccharomyces cerevisiae; Signal Transduction | 2021 |